According to a new market research report "Digital PCR (dPCR) and qPCR Market by Technology, Product (Instruments, Reagents, Software), End User (Research Lab, Academia, Hospitals, Pharmaceutical & Biotechnology Cos, CROs), Application (Research, Diagnostic, Forensic) Global Forecast to 2019", this report studies the global digital PCR (dPCR) and qPCR market over the forecast period of 2014 to 2019. The market is expected to reach $3.97 billion by 2019, at CAGR of 7.8% from 2014 to 2019.
Browse 90 market data tables and 69 figures spread through 215 pages and in-depth TOC on “Digital PCR (dPCR) and qPCR Market".
Early buyers will receive 10% customization on this report.
Based on the type of technology, the global digital PCR (dPCR) and qPCR market is classified into two major segments, namely, real-time PCR (qPCR) technology and digital PCR (dPCR) technology segments. Moreover, based on type of products, the global digital PCR (dPCR) and qPCR market is classified into two product segments, namely, qPCR product segment, and dPCR product segment. Each of the qPCR and dPCR product segments is further sub-divided into instruments, reagents and consumables, and softwares and services, respectively. The analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=174151204
The global digital PCR (dPCR) and qPCR market is further classified into two end-user segments, namely qPCR end-users and dPCR end-user segments. Each of the qPCR and dPCR end-user sub-segments include research laboratories and academic institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, clinical research organizations (CROs), and forensic laboratories. Additionally, the global digital PCR (dPCR) and qPCR market segmented based on applications into qPCR applications and dPCR applications. Each of the qPCR and dPCR application market is further divided into research, clinical, and forensic applications, respectively.
A number of factors such as growing geriatric population, technological advancements, rising incidence of infectious diseases and genetic disorders, and increased public-private investments, funds, and grants are driving the growth of the global digital PCR (dPCR) and qPCR market. On the other hand, factors such as high cost of dPCR instruments and limitations of qPCR and dPCR techniques are restricting the growth of the global digital PCR (dPCR) and qPCR market.
You can speak To Research Analyst to know more about Report:
As of 2014, North America holds the largest share of the digital PCR (dPCR) and qPCR market, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR of ~10.7% from 2014 to 2019. A number of factors such as increase awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel dPCR and qPCR technologies, rise of Indian genomics market, and strengthening cancer research in Japan, increasing focus of global life science companies in emerging markets are stimulating the growth of the digital PCR (dPCR) and qPCR market in the Asia-Pacific region.
Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Agilent Technologies Inc. (U.S.), BioMerieux SA (France), Takara Bio (Japan), RainDance Technologies, Inc. (U.S.), Eppendorf AG (Germany), and BioSistemika Research and Development LLC (Slovenia) are the major players in the global digital PCR (dPCR) and qPCR market.
Browse Related Reports:
Next Generation Sequencing (NGS) Market by Platforms (Illumina HiSeq, MiSeq, HiSeqX Ten, NextSeq 500,Thermo Fisher Ion Proton/PGM), Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT) & by Application (Diagnostics, Personalized Medicine) - Global Forecast to 2020.
Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnologyConnect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets